SHC Earnings & Financial Statements
Sotera Health Company
$17.73
-$0.48(-2.64%)
41
Overall
40
Value
30
Tech
55
Quality
Market Cap
$5.06B
Volume
2.28M
52W Range
$13.09 - $19.85
Target Price
$22.72
SHC earnings and financial statements: Sotera Health Company's income statement, balance sheet and cash flow statement, annual and quarterly.
SHC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $1.16B | $1.10B | $1.05B | $1.00B | $931.48M |
| Cost of revenue | $518.08M | $498.15M | $472.13M | $446.68M | $55.60M |
| Operating income | $392.77M | $359.67M | $276.69M | $248.35M | $256.73M |
| EBITDA | $445.37M | $449.44M | $415.88M | -$11.73M | $335.29M |
| Net income | $77.95M | $44.40M | $51.38M | -$233.57M | $116.88M |
| EPS (diluted) | $0.27 | $0.16 | $0.18 | $-0.83 | $0.41 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $3.26B | $3.07B | $3.13B | $3.12B | $2.79B |
| Total liabilities | $2.66B | $2.67B | $2.69B | $2.77B | $2.20B |
| Shareholders’ equity | $606.03M | $404.91M | $443.73M | $350.24M | $586.10M |
| Cash and equivalents | $344.62M | $277.24M | $296.41M | $395.21M | $106.92M |
| Long-term debt | $2.25B | $2.33B | $2.31B | $1.83B | $1.82B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $287.19M | $224.16M | -$147.73M | $277.96M | $281.55M |
| Capital expenditure | -$138.02M | -$179.07M | -$214.97M | -$182.38M | -$102.16M |
| Free cash flow | $149.18M | $45.09M | -$362.71M | $95.58M | $179.38M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SHC | $17.73 | -2.6% | 2.28M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |